GeoVax Labs(GOVX) - 2025 Q2 - Earnings Call Transcript

GeoVax Labs (GOVX) Q2 2025 Earnings Call July 28, 2025 04:30 PM ET Company ParticipantsDavid Dodd - Chairman, President & CEOMark Reynolds - CFOJohn W. Sharkey - VP - Business DevelopmentKelly McKee - Chief Medical OfficerJames Molloy - MD & Equity Research - Biotechnology and Specialty PharmaceuticalsConference Call ParticipantsJonathan Aschoff - MD & Senior Research AnalystRobert Leboyer - Senior Biotechnology AnalystJohn Vandermosten - Senior AnalystOperatorGood afternoon, and welcome, everyone, to the G ...